https://www.selleckchem.com/pr....oducts/hmpl-504-azd6
We divided eligible patients for secondary cytoreduction in relation to the following factors platinum-sensitivity, AGO-score or Tian model, unresectable lesions, surgical generic contraindication, woman's personal choice. The selection of truly suitable patients for surgery seems an essential requirement for the patient's best therapeutic choice. In case of absent post-surgical residual tumor, good performance status, single recurrence, and platinum-sensitive ovarian recurrence, surgery could be performed.Ovarian can
Like
Comment
Share
